ARTICLE | Company News
Vertex, Cystic Fibrosis Foundation deal
March 27, 2006 8:00 AM UTC
VRTX will receive $13.3 million from Cystic Fibrosis Foundation Therapeutics Inc. (CFFT), the drug discovery arm of the foundation, to support development of VX-770 to treat cystic fibrosis (CF) thr...